Someone just saved $2.17 off their order, 22 minutes ago!
✔ Last used 22 minutes ago
Someone just saved $3.60 off their order, 24 minutes ago!
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..